The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 19, 2011
Filed:
Apr. 05, 2007
Thomas Daniel Aicher, Superior, CO (US);
Peter Biagio Anzeveno, Zionsville, IN (US);
Renhua LI, Fishers, IN (US);
Alexei Pavlovych Krasutsky, Zionsville, IN (US);
Thomas Edward Mabry, Indianapolis, IN (US);
Ashraf Saeed, Westfield, IN (US);
Nancy June Snyder, Lizton, IN (US);
Hongqi Tian, Longmont, CO (US);
Owen Brendan Wallace, Westfield, IN (US);
Leonard Larry Winneroski, Greenwood, IN (US);
Yanping Xu, Noblesville, IN (US);
Thomas Daniel Aicher, Superior, CO (US);
Peter Biagio Anzeveno, Zionsville, IN (US);
Renhua Li, Fishers, IN (US);
Alexei Pavlovych Krasutsky, Zionsville, IN (US);
Thomas Edward Mabry, Indianapolis, IN (US);
Ashraf Saeed, Westfield, IN (US);
Nancy June Snyder, Lizton, IN (US);
Hongqi Tian, Longmont, CO (US);
Owen Brendan Wallace, Westfield, IN (US);
Leonard Larry Winneroski, Greenwood, IN (US);
Yanping Xu, Noblesville, IN (US);
Eli Lilly and Company, Indianapolis, IN (US);
Abstract
The present invention discloses novel compounds of Formula (I): having 11β-HSD type 1 antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I), as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11β-HSD type 1 activity.